Molecular monitoring in chronic myeloid leukemia patients who achieve complete cytogenetic remission on imatinib

被引：13
|
作者：
Lin, F [1 ]
Drummond, M [1 ]
O'Brien, S [1 ]
Cervantes, F [1 ]
Goldman, J [1 ]
Kaeda, J [1 ]
机构：
[1] Hammersmith Hosp, Imperial Coll Sch Med, Dept Haematol, London W12 0NN, England
来源：
BLOOD | 2003年 / 102卷 / 03期
关键词：
D O I：
10.1182/blood-2002-12-3916
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1143 / 1143
页数：1
相关论文
共 50 条
  • [1] Molecular remission in chronic myeloid leukemia patients with sustained complete cytogenetic remission after imatinib mesylate treatment
    Colombat, M
    Fort, MP
    Chollet, C
    Marit, G
    Roche, C
    Preudhomme, C
    Reiffers, J
    Praloran, V
    Mahon, FX
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2006, 91 (02): : 162 - 168
  • [2] Adherence Is the Critical Factor for Achieving Molecular Responses in Patients With Chronic Myeloid Leukemia Who Achieve Complete Cytogenetic Responses on Imatinib
    Marin, David
    Bazeos, Alexandra
    Mahon, Francois-Xavier
    Eliasson, Lina
    Milojkovic, Dragana
    Bua, Marco
    Apperley, Jane F.
    Szydlo, Richard
    Desai, Ritti
    Kozlowski, Kasia
    Paliompeis, Christos
    Latham, Victoria
    Foroni, Letizia
    Molimard, Mathieu
    Reid, Alistair
    Rezvani, Katy
    de Lavallade, Hugues
    Guallar, Cristina
    Goldman, John
    Khorashad, Jamshid S.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (14) : 2381 - 2388
  • [3] HIGH DOSE IMATINIB TO ACHIEVE MOLECULAR RESPONSES IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN LATE CHRONIC PHASE AND COMPLETE CYTOGENETIC RESPONSE: IS IT WORTHWHILE?
    Stagno, F.
    Vigneri, P.
    Massimino, M.
    Del Fabro, V.
    Stella, S.
    Berretta, S.
    Messina, A.
    Di Raimondo, F.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 433 - 433
  • [4] Clonal cytogenetic abnormalities in patients with chronic myeloid leukemia in complete cytogenetic response to imatinib mesylate
    Espinet, Blanca
    Carla Oliveira, Ana
    Boque, Concepcion
    Domingo, Alicia
    Alonso, Esther
    Sole, Francesc
    HAEMATOLOGICA, 2005, 90 (04) : 556 - 558
  • [5] Sustained Complete Molecular Remission after Imatinib Discontinuation in Children with Chronic Myeloid Leukemia
    Moser, Olga
    Krumbholz, Manuela
    Thiede, Christian
    Tauer, Josephine T.
    Janz, Indra
    Lauten, Melchior
    Dilloo, Dagmar
    Metzler, Markus
    Suttorp, Meinolf
    PEDIATRIC BLOOD & CANCER, 2014, 61 (11) : 2080 - 2082
  • [6] Sustained complete cytogenetic remission in a patient with chronic myeloid leukemia after discontinuation of imatinib mesylate therapy
    Seiichi Okabe
    Tetsuzo Tauchi
    Yuko Ishii
    Daigo Akahane
    Kousuke Nunoda
    Seiko Honda
    Tomoiku Takaku
    Kazuma Ohyashiki
    International Journal of Hematology, 2007, 85 : 173 - 174
  • [7] Sustained complete cytogenetic remission in a patient with chronic myeloid leukemia after discontinuation of imatinib mesylate therapy
    Okabe, Seiichi
    Tauchi, Tetsuzo
    Ishii, Yuko
    Akahane, Daigo
    Nunoda, Kousuke
    Honda, Seiko
    Takaku, Tomoiku
    Ohyashiki, Kazuma
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2007, 85 (02) : 173 - 174
  • [8] Sudden blast crisis in patients with Philadelphia chromosome-positive chronic myeloid leukemia who achieved complete cytogenetic remission after imatinib therapy
    Alimena, Giuliana
    Breccia, Massimo
    Latagliata, Roberto
    Carmosino, Ida
    Russo, Eleonora
    Biondo, Francesca
    Diverio, Daniela
    Mancini, Marco
    Nanni, Mauro
    Mandelli, Franco
    CANCER, 2006, 107 (05) : 1008 - 1013
  • [9] COMPLETE MOLECULAR RESPONSE IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA ON IMATINIB THERAPY
    Aksenova, E.
    Chelysheva, E.
    Krutov, A.
    Soldatova, I.
    Misiurin, A.
    Vinogradova, O.
    Gusarova, G.
    Zakharova, E.
    Sokolova, M.
    Nemchenko, I.
    Kuznetsov, S.
    Lazareva, O.
    Vorontsova, A.
    Kolosheinova, T.
    Kolosova, L.
    Goryacheva, S.
    Ivanova, T.
    Turkina, A.
    Khoroshko, N.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 346 - 346
  • [10] DISCONTINUATION OF IMATINIB (IM) IN PEDIATRIC CHRONIC MYELOID LEUKEMIA (CML) PATIENTS WITH SUSTAINED COMPLETE MOLECULAR REMISSION (CMR)
    Giona, F.
    De Vellis, A.
    Moleti, M.
    Gottardi, E.
    Rea, M.
    Nanni, M.
    Testi, A.
    Diverio, D.
    Saglio, G.
    Foa, R.
    HAEMATOLOGICA, 2013, 98 : 65 - 65
12345